PUBLIC CONTRACT · 2024
Eculizumab 300 mg conc.para sol perfusão fr 30ML IV (PC.01678.2024)
- Contract value
- €77,854.80
- Signed on
- 29 May 2024
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10763571PUBLISHED SUBJECT
ECULIZUMAB 300 MG CONC.PARA SOL PERFUSÃO FR 30ML IV (PC.01678.2024)
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Viseu, Viseu
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ALEXION PHARMA SPAIN S L - SUCURSAL PORTUGAL · Tax ID 980553768
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €77,854.80
- Procedure base price
- €77,854.80
- Total effective price
- Not reported on Portal BASE
- Publication date
- 12 June 2024
- Award date
- 29 May 2024
- Signing date
- 29 May 2024
- Performance period
- 92 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7087275
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.